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cells into osteoprogenitor cells), and it con-
tains progenitor cells that are able to ini-
tiate osteogenesis (forming bone from the 
interior of transplanted material). In addi-
tion to that, autologous bone poses virtu-
ally no risk of immunogenic response.[2]
The drawbacks of the use of autologous 
bone grafts are tied with the finite supply 
(5–70 cm3) as well as with the harvesting 
procedure. The graft is usually taken from 
the iliac crest, a procedure that is associ-
ated with minor (10–39% of cases) and 
major (0.76–25% of cases) complications. 
A relatively new method using a reamer–
irrigator–aspirator (RIA) device harvests 
bone fragments from the intramedullary 
canal with potentially lower complication 
rates (overall 6%); however, this method is 
not yet as widespread as harvesting from 
iliac crest bone.[3]
Eliminating the autologous harvesting 
procedure by using bone graft substitutes 
is obviously very attractive, and alterna-
tives including allogeneic grafts (human 
derived), xenogeneic grafts (animal 
derived), or synthetic bone graft substi-
tutes are abundantly described in the literature, and are also 
used in the clinical setting.[4,5] Allogeneic and xenogeneic bone 
grafts suffer from disadvantages related to their origin, being 
the risk of immune reactions and disease transmission. Syn-
thetic bone graft substitutes lack these drawbacks and have the 
potential to perform as well as autologous bone graft, but have 
the additional challenge of doing so while remaining affordable.
The affordability issue precludes, to some extent, the use 
of cell- and growth factor-based tissue engineering scaffolds 
despite some clinical successes.[6–9] Other associated drawbacks 
are related to cell survival upon implantation,[10] and diffusion 
of growth factors into surrounding tissue, possibly causing 
ectopic bone formation that may lead to complications and 
often requires surgical intervention.[11–13]
A systematic review on biomaterial-based bone graft substi-
tutes for use in the orthopedics, performed in the UK showed 
that only 4 out of 59 commercially available products were dem-
onstrated to perform equally or better than bone autograft.[4] 
These products were Alpha-BSM (DePuy),[14,15] a resorbable 
calcium phosphate paste, Cortoss (Orthovia),[16] a nonresorb-
able bioactive glass cement, Vitoss (Orthovia),[17] a resorbable 
composite of calcium phosphate and collagen, and Norian SRS 
(Synthes),[18] a resorbable CaP cement. Strikingly, Vitoss is 
the only product showing signs of osteoinduction, a property 
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Biomineralization
1. Introduction
1.1. Bone Graft Substitutes
Currently, over 2 million bone grafting procedures are per-
formed annually worldwide, and this number is predicted to 
increase.[1]
Autologous bone grafting is the current standard of care for 
bone defects that do not heal spontaneously for a variety of 
reasons. The structural organization of a patient’s own tissue 
provides an environment for osteoconduction (migration of 
osteogenic host cells into the transplanted material), its chem-
ical composition and associated growth factors support osteoin-
duction (induction of differentiation of undifferentiated stem 
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considered essential for successful bone regeneration of large 
bone defects. Also important to note is that most of the prod-
ucts available are based on calcium phosphates, the exception 
being the bioglass cement, which has similar properties to 
CaPs in that it possesses tunable degradability and allows direct 
contact with bone tissue. Despite the proven bioactivity, none 
of these materials are able to sustain loads by themselves, and 
therefore they are typically used in combination with (metallic) 
fixation instruments.[4]
This is the current challenge for bone graft substitutes: 
having load-bearing capacity comparable to cortical bone, suf-
ficient bioactivity (osteoconduction and induction) to elicit 
new bone formation, and degrading as it is replaced by newly 
formed native tissue.[19] All these properties are combined in 
the natural bone tissue, originating from its composition and 
hierarchical structural organization. Natural bone is therefore 
a logical source of inspiration for developing novel biomaterials 
for bone repair and regeneration.
1.2. Aim
What is the state of the art in developing nature-inspired/bio-
mimetic bone graft substitutes and what are the promises for 
the future?
These are the main questions that this review aims to 
answer, by critically analyzing recent developments in the bio-
materials field, inspired from advances in the field of biomin-
eralization, leading to materials that are close to natural bone 
in structure and composition. The goal is to comprehensively 
cover the strategies to reproduce various properties of extracel-
lular bone matrix, ranging from the chemical composition of 
the mineral phase to mechanical properties stemming from 
3D hierarchical structures. The key challenges that need to be 
tackled at each length scale are highlighted as well as possible 
ways to overcome them.
To provide adequate background, the next section contains 
a short introduction to the extracellular matrix (ECM) of bone 
as context for discussion of achievements in bone-mimicking 
biomaterials research and development.
1.3. Bone Structure and Composition
Regarding the composition and structure of bone, it is impor-
tant to recall that the focus is on secondary, or lamellar bone, 
in contrast to primary or woven bone. Secondary bone is found 
in mature bones, in the form of cortical (dense, compact) or 
cancellous (spongy, trabecular) bone. The lamellar bone tissue 
is remodeled from primary bone, which can be formed by 
endochondral ossification (mineralization of preexisting carti-
lage template) or by intramembranous ossification (direct bone 
formation).
The overall composition of the extracellular matrix of bone, 
excluding the various cell types that populate the matrix, is 
about 25 wt% organic component, 65 wt% inorganic compo-
nent, and 10 wt% water content. Water is found in pores and 
channels within the bony matrix (5–20% of the total water pre-
sent in bone), as well as in close association with the collagen 
fibrils and apatite mineral. In particular the latter, bound water, 
contributes to the plastic behavior of bone and its ability to 
absorb energy, with a decrease in water content due to aging 
resulting in a lower resistance to fracture.[20] Starting from 
basic components to a whole bone, an overview of structure 
and organization of the matrix is given below.
1.3.1. Organic Phase
The organic matrix of bone comprises around 90 wt% type I 
fibrillar collagen and 10 wt% noncollagenous proteins. Collagen 
molecules aggregate in triple helices—tropocollagen—that are 
300 nm long and 1.5 nm wide. These are stacked longitudinally 
with a gap of 40 nm, and having a lateral spacing of 1–2 nm.[21] 
A collagen fibril (about 100 nm in diameter) is made up of 
staggered rows of axially packed, tropocollagen molecules with 
lateral crosslinks (Figure 1).[22] These crosslinks can be enzy-
matic or nonenzymatic. The enzymatic links are further divided 
into immature (divalent) and mature (trivalent) crosslinks, and 
their total amount and ratio are related to the mechanical prop-
erties of bone, such as stiffness, tensile strength, and fracture 
toughness. The nonenzymatic crosslinks result from accumu-
lation of advanced glycation end (AGE) products and are cor-
related with increased bone brittleness in aging or disease.[23] 
The staggering of rows creates periodic density variations in the 
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fibril, visible in transmission electron microscopy (TEM) due 
to the misalignment of the gaps between molecules.[24] These 
nanoscale spaces within the collagen fibril are templates that 
are populated by mineral during bone formation.
While collagen is the main organic component of the extra-
cellular matrix, the matrix contains a multitude of other noncol-
lagenous proteins (NCPs). The roles of these proteins are still 
not completely understood; for a comprehensive overview of 
the available knowledge of these proteins we refer to the review 
by Zhu et al.[25] Table 1 highlights the NCPs that are thought 
to have a structural role (i.e., they are present in the matrix at 
some point) in the formation and regulation of the extracel-
lular matrix. This excludes enzymes (e.g., alkaline phosphatase 
despite its role in phosphate liberation) or growth factors (e.g., 
bone morphogenetic proteins despite their role in promoting 
mineralization). Most NCPs have a regulatory function in the 
process of biomineralization, but some also have direct implica-
tions for the mechanical properties of bone. Osteopontin (OPN) 
is hypothesized to play a role in preventing crack propagation: 
OPN-deficient mice showed 30% less resistance to fracture.[26] 
OPN and osteocalcin were furthermore shown to influence 
the formation of sub-micrometer gaps, called dilational bands, 
between adjacent mineral aggregates. The formation of these 
dilational bands was correlated with diffuse damage at the 
micrometer scale and increased resistance to fracture.[27]
1.3.2. Mineral Phase
Bone mineral, or bone apatite, can be found inside the collagen 
fibril (intrafibrillar mineral) as well as surrounding it (extrafi-
brillar mineral) although their relative fractions are a matter of 
dispute.[28,29] In a recently published analysis of the morphology 
of the mineral particles, obtained by 3D reconstruction of 
tomography data from ion-milled bone slices, imaged by scan-
ning transmission electron microscopy, classification in four 
hierarchical categories was made. Thin (5 nm base), elongated 
(50–100 nm) and curved crystals aggregate laterally (width 
20–30 nm) to form the platelets often described in literature.[30] 
These can be further organized into thicker stacks of two to 
four platelets, or into aggregates of all the previous structures, 
forming complex shapes up to 300 nm.[31]
The chemical composition of bone apatite is far from the 
stoichiometric hydroxyapatite as it is highly substituted with 
ions from the physiological fluids. These substitutions can 
occur in any of its four crystallographic domains: the PO43− tet-
rahedral positions, the Ca2+(I) positions (phosphate surrounded 
hexagonal columns) or Ca2+(II) positions (staggered triangular 
surrounding hydroxide) or in the OH− “channel” positions.[32] 
The precise composition of ion substitutes tends to vary among 
subjects and depending on the type of bone itself, but in gen-
eral the following ions are present: CO32− (around 5 wt%), Na+ 
and Mg2+ (both between 0.5 and 1 wt%),[30,33,34] K+, Sr2+, Cl−, F− 
(up to 0.1%), and trace amounts (in the ppm range) of several 
other metallic elements: B, Al, Si, Ti, Cr, Mn, Fe, Co, Zn, Sr, 
Cd, La, and Pb.[35–37] There is debate about whether the crystal-
lographic unit cell is hexagonal or monoclinic.[30,38]
Mineral platelets are hypothesized to be closely related to the 
citrate anion, which is present in high concentration in bone.[39] 
The role of citrate is not yet well defined although evidence 
exists relating it to the restriction of apatite crystal growth[40,41] 
and to the stabilization of an amorphous calcium phosphate 
phase.[42]
1.3.3. Mineralized Collagen Fibril
The components described so far, the structural collagen 
matrix, noncollagenous proteins and molecules, and the apa-
tite platelets, come together in what is considered to be the 
building block of the extracellular matrix of bone: the mineral-
ized collagen fibril (Figure 1).[148]
Adv. Healthcare Mater. 2018, 7, 1800700
Figure 1. Schematic of the hierarchical structure of bone. Collagen molecules, with unique amino acid sequence, are assembled into triple helices, 
forming what is known as a tropocollagen molecule. Tropocollagen molecules come together with apatite crystallites in the collagen fibril, the building 
block of bone. Collagen fibrils further associates into bundles, lamellae, and finally osteons, the microscale structure of bone. Trabecular or spongy 
bone is porous and resides in the interior of, for example, long bones, while the compact bone is much less porous and is present at the exterior. 
Reproduced with permission.[148] Copyright 2015, Nature Publishing Group.
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The small dimensions of crystallites, their highly substi-
tuted chemical phase, and close associations with collagen and 
other organic molecules make it rather difficult to precisely 
characterize this unit block although more is known about its 
composition (described in the previous section) than about 
the mechanisms by which it is formed. The 3D arrangement 
of apatite and collagen at the nanoscale has also been recently 
described.[31]
The mounting evidence for amorphous precursors in the 
formation stages of bone from different vertebrates, namely 
in zebrafish fin rays,[43–45] mouse calvaria and long bones,[46,47] 
as well as in enamel in mouse,[48] points toward a nonclassical 
mineralization pathway.[49] This is substantiated with an in vitro 
study on the formation of amorphous calcium phosphate (ACP) 
that correlates with the ACP phase found in vivo.[50] The process 
of collagen mineralization by an amorphous precursor is likely 
assisted by NCPs that stabilize ACP and interact with collagen, 
as shown in in vitro models for DPP, DMP1,[51,52] OPN,[53] 
and AHSG,[54–56] as well as by a study on remineralization of 
DBM.[57] Carbonate has also been hypothesized to have a role 
in the formation of first mineral domains, but at the moment 
only limited in vitro evidence exists.[58–60] Therefore, much is 
still to be discovered about the mechanisms of mineralization 
regulated by organic components.[61]
1.3.4. Fibril Arrays, Lamella, and Osteons
Mineralized collagen fibrils (about 100 nm) bundle together in 
fibril arrays (sometimes called fibers), and these are arranged 
in parallel stacks. A lamella consists of typically parallel fibril 
arrays (in the range of 100 nm to 10 µm). Lamella can be 
stacked in different ways,[62] for example, in parallel stacks, with 
a slight angle offset, or alternating at sharp angles.[63,64]
Osteons are the hallmark structure of secondary bone, and 
they have a diameter of around 100 µm. An osteon consists of 
a central (Haversian) canal, occupied by a blood vessel, and sur-
rounded by concentric lamella (Figure 1). Canals perpendicular 
to the Haversian canal, the so-called Volkmann canals, link 
adjacent osteons. Lacunae, with resident osteocytes, populate 
the bone surrounding the Haversian canal, with their long 
axis concentric to the Haversian canal. Canaliculi extend from 
the lacunae, linking adjacent osteocytes to each other and to a 
filtering surface.
Adv. Healthcare Mater. 2018, 7, 1800700
Table 1. Noncollagenous structural proteins involved in the formation or regulation of the extracellular matrix.
Noncollagenous protein Known or hypothesized role
Large proteoglycans
Versican (VCAN) Present in early stages of bone development.[149] Contains EGF-like sequences that may affect osteogenic 
differentiation.[150,151]
Small leucine-rich repeat proteoglycans (SLRPs)
Decorin (DCN) and biglycan (BGN) Regulators of collagen fibrillogenesis.[152,153] Decorin possibly modulates collagen mineralization.[154] Biglycan is 
involved in angiogenesis during fracture healing,[155,156] and osteoblast differentiation.[157]
Osteomodulin (OMD) Involved in the organization of the collagen matrix.[158]
Asporin (ASPN) Possible role in collagen mineralization.[159,160]
Fibromodulin (FMOD) and lumican (LUM) Involved in the organization of the collagen matrix.[161]
Glycoproteins
Osteonectin (SPARC) Affinity to collagen and hydroxyapatite, involved in collagen mineralization.[162,163]
Tetranectin (CLEC3B) Possibly involved in fracture healing.[164]
RGD-containing glycoproteins
Thrombospondin-2 (THBS2) Involved in the organization of the collagen matrix.[165]
Fibronectin (FN1)
and vitronectin (VTN) Possibly providing attachment points to various cell types.[166]
Small integrin-binding ligands with N-linked glycosilation (SIBLINGs)
Osteopontin (SPP1) Affinity to collagen and hydroxyapatite, known inhibitor of ectopic calcification, modulator of bone mineralization.[167]
Bone sialoprotein (IBSP) Affinity to collagen and hydroxyapatite, induces differentiation of osteoblasts and is a mineralization promoter.[168,169]
Dentin matrix protein 1 (DMP1) Involved in bone mineralization, likely promoter of mineralization.[51,170]
Matrix extracellular phosphoglycoprotein (MEPE) Involved in bone mineralization, likely inhibitor of mineralization.[171–173]
Bone acidic glycoprotein 75 (BAG-75) Possibly involved in early stages of bone mineralization.[174–176]
γ-Carboxy glutamic acid proteins
Matrix gla protein (MGP) Inhibitor of mineralization.[177,178]
Osteocalcin (BGLAP) Regulator of mineralization.[173,179,180]
Serum proteins
Albumin (ALB) and α2-HS-glycoprotein (AHSG) Both have affinity to Ca2+, inhibiting hydroxyapatite mineralization by arresting crystal growth. AHSG does so to a 
greater extent than albumin.[181,182]
1800700 (5 of 18)
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1.3.5. Cortical and Trabecular Bone
Cortical bone forms the hard shell–like surface of a bone, while 
trabecular bone fills its core. Porosity distinguishes cortical 
(≈6%) and trabecular bone (≈80%)). While osteons are packed 
together in cortical bone, in trabecular bone the mineralized 
matrix is sparse, consisting of interconnected struts of about 
200 µm (Figure 1). These trabeculae undergo constant remod-
eling, and their orientation and local density depend on the 
typical load applied to the bone.[21] The pores in this sponge-like 
structure house the bone marrow.
2. Biomineralization-Inspired Materials
In the following section, examples of biomaterials are given 
that possess closer-to-bone characteristics. The focus is on dis-
cussing the state-of-the-art of bone-mimicking or bone-inspired 
biomaterials, and having a critical comparison of such mate-
rials with the natural extracellular matrix.
2.1. Mimicking the Building Block of Bone
When ascertaining to what level an artificially produced min-
eralized collagen fibril replicates the building block found in 
natural bone, there are several key points to keep in mind 
(Figure 2). One is the high mineral content of the natural 
nanocomposite, of around 65 wt%, that can, for example, be 
shown by thermal gravimetric analysis (TGA) (Figure 2g). 
The second is a homogenous mineralization throughout the 
developed substrate that can be demonstrated using elemental 
surface analysis methods such as energy-dispersive X-ray 
spectroscopy (EDS) mapping performed on different areas 
(Figure 2b–c). Third, there must be evidence of the close rela-
tionship between the apatite mineral and the collagen matrix, 
which can be observed by scanning electron microscopy 
(SEM) and EDS, or TEM. Fourth, proof that mineralization is 
intrafibrillar, which can be obtained by a combination of indi-
rect methods, or directly, by the use of 3D imaging techniques. 
Indirectly, intrafibrillar mineralization can be evidenced by a 
combination of techniques that show that the composite has 
a high mineral content (e.g., TGA), while the normal ultras-
tructure and surface of the organic matrix is maintained (e.g., 
SEM-EDS), leading to the conclusion that the mineral must 
reside within the organic matrix. The latter analysis should 
show that at early time points, no extrafibrillar mineral is pre-
sent, as mineralization typically starts from the inside out, 
leaving the collagen surface unaltered (Figure 2a). Unequiv-
ocal proof of intrafibrillar mineralization can be obtained with 
3D imaging techniques such as cryogenic electron tomog-
raphy (Figure 2h) or, alternatively, by clever use of super-
resolution microscopy techniques such as stochastic optical 
reconstruction microscopy, used to image fluorescent calcein-
labeled apatite, to show its localization within immuno-labeled 
collagen fibrils (Figure 2i). Last, it is important to show that 
the mineral present is similar to bone apatite, in composition, 
particle size and orientation. Data from selected-area electron 
diffraction (SAED) in combination with TEM imaging covers 
all three, by revealing the angles and d-spacing characteristic 
of apatite mineral and proving that the orientation of the 
crystallographic c-axis is along the longitudinal axis of the col-
lagen fibril (Figure 2d–f).
In the context of reconstituting the main building block of 
bone, i.e., the mineralized collagen fiber, the discovery of the 
so-called polymer-induced liquid precursor (PILP) process has 
had a major impact. This process, which was observed in the 
in vitro experiments on the stabilization of amorphous mineral 
phases, was initially described for calcium carbonate[65] and 
later for CaP.[30] The PILP process encompasses, in the case of 
CaP, the stabilization of hydrated clusters of Ca2(HPO4)32− that 
form from saturated solutions,[50] by charged (typically ani-
onic) polymers, effectively creating stable amorphous calcium 
phosphate–polymer particles.
The ACP–polymer complexes are capable of infiltrating pre-
assembled collagen fibrils through the a-band of the 40 nm 
gap region of collagen.[56] The mineral then crystallizes inside 
the fibril, resulting in mineralized collagen fibrils that have 
a remarkable resemblance to mineralized collagen found in 
natural bone. More specifically, the intrafibrillar mineral con-
sists of crystallites with the c-axis orientation in the direction of 
the fibril.[30] The exact mechanism of infiltration is still under 
debate, and various hypotheses suggest the importance of elec-
trostatic interactions,[50,56] capillary-like forces,[30] mineralization 
by inhibitor exclusion,[55] or simultaneous fibrillogenesis and 
apatite formation.[66] Interestingly, the fact that intrafibrillar min-
eralization of collagen was achieved via an amorphous precursor 
in vitro prompted the biomineralization community to renew 
efforts in investigating the role of such precursors in the in vivo 
biomineralization process. These efforts resulted in the con-
firmation that indeed, in the process of formation of zebrafish 
fin rays, and mouse calvaria, long bones, and enamel, an amor-
phous precursor is present, as mentioned in the introductory 
section.[43,45–48,67] Since early 2000, a range of experiments have 
been performed that have increased our understanding of the 
process of intrafibrillar mineralization of collagen and bone 
biomineralization, as well as provided useful tools for devel-
oping truly biomimetic materials for bone regeneration.
A large majority of approaches to obtain intrafibrillar col-
lagen mineralization employs polymeric process-directing 
agents; however, in a few studies the process was performed 
in the absence of NCPs or their analogs. For example in a 
study by Wang et al., the authors employed simultaneous col-
lagen fibrillogenesis and precipitation of carbonated apatite. 
This approach proved capable of forming intrafibrillar mineral, 
with orientation of the crystallographic c-axis in the collagen 
fibril direction, as shown by TEM-SAED and SEM micro-
scopic images. The mineral content, determined using TGA, 
was 32 wt% after a 4 day reaction (calculated relative to the dry 
composite, taken as wt% left at 200 °C). The mineralization 
was extended by a 16 day immersion in a simulated body fluid, 
resulting in an increase of mineral content up to 50 wt% of the 
dry mass.[66] While this work proved that NCPs, or their ana-
logs are not necessary to achieve intrafibrillar mineralization of 
collagen, the mineralization extent in this study falls somewhat 
short of the expected 65 wt%. Furthermore, while it is expected 
that the mineral deposited during the first phase is homoge-
neously spread throughout the scaffold, this is less certain for 
Adv. Healthcare Mater. 2018, 7, 1800700
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Figure 2. Characterization of intrafibrillar-mineralized collagen. a) SEM image of a collagen scaffold mineralized for 3 days, showing a typical surface 
morphology of the organic matrix, while EDS spectrum (inset) shows the presence of Ca and P, associated with CaP mineralization; b) SEM image of a 
remineralized piece of manatee bone, with c) EDS spectra collected along the red line, showing heterogeneous Ca and P distribution on the cross section, 
suggesting that infiltration of the pAsp–ACP complex was not complete; d) bright field TEM image of a mineralized collagen fibril and e) corresponding 
SAED pattern, showing characteristic 002 reflection aligned with the fibril, and ring composed of the 112, 211, and 300 reflections; f) dark field TEM image 
made with the beam from the 002 reflection, showing crystals distribution within the collagen fibril; g) TGA of PILP-mineralized collagen sponges showing 
that increasing degree of crosslinking (X0: control; X26 < X59 < X82) promotes increase in mineral content; h) cryo-ET of a mineralized collagen fibril 
showing the plane of section through the middle of the fibril, with magnified regions identified by yellow squares, where apatite platelets are visible as dark 
streaks (white arrows). On the right a 3D reconstruction of the apatite platelets embedded in the collagen fibril: i) STORM images of calcein-labeled apatite 
(red) and immunostained collagen (green), imaged in a z-stack ranging 0–240 nm, showing the presence of apatite within the collagen fibril. (a) Reproduced 
with permission.[77] Copyright 2010, Elsevier. (b,c) Reproduced with permission.[69] Copyright 2011, Elsevier. (d–g) Reproduced with permission.[80] Copyright 
2011, American Chemical Society. (h) Reproduced with permission.[56] 2010, Nature Publishing Group. (i) Reproduced with permission.[97] 2018, Wiley-VCH.
1800700 (7 of 18)
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the second phase, where the substrate is already dense and 
mineralized before immersion in the SBF solution. Indeed, 
cryo-TEM microscopic images of the scaffold showed fibrils 
ranging from not mineralized to fully mineralized. Comple-
mentary SEM-EDS analyses at different depths across the 3 mm 
thick disc would have given a valuable insight in the homoge-
neity of mineral distribution throughout the dense substrate.
In another study by Marelli et al., it was hypothesized that 
the pH at which collagen fibrils are formed influences intrafi-
brillar mineralization. Using cationic or anionic dyes, it was 
confirmed that collagen gels formed under mild alkaline condi-
tions (pH = 9.0) had more negative charges than gels formed 
under neutral conditions (pH = 7.4). After mineralization in 
SBF for 14 days, the negatively charged gel had 64 wt% more 
mineral deposited than the positively charged one. Although 
this was presented as intrafibrillar mineral, no conclusive evi-
dence was provided to support this statement. The TEM image 
of the gel after 24 h of incubation in SBF showed mineral 
agglomerates together with a collagen fibril, but the exact loca-
tion of the mineral (adjacent to, on top of, or inside the fibril) 
was not clear. The supplementary SEM images strongly sug-
gested that the mineral formed was actually extrafibrillar, and 
the authors were careful to phrase the figure captions as “min-
eral formation within the collagen framework,” which suggests 
that the formation occurred inside the collagen gel, but that it 
was not necessarily intrafibrillar.
Among the different polymeric additives that have been 
explored in the context of mineralization with process-
directing agents, poly(aspartic acid) (pAsp) is the most com-
monly used.[30,52,56,57,68–80] Other polymer additives include 
poly(glutamic acid) (pGlu),[79,81,82] poly(amidoamine) den-
drimers,[83,84] poly(acrylic acid) (PAA),[69,81] typically used in 
combination with poly(vinylphosphonic acid) (PVPA),[79,81,85,86] 
sodium trimethaphosphate (STMP),[87] poly(glutamic acid),[88] 
or phosphorylated collagen.[89,90] The only example of a cationic 
polymer able to induce intrafibrillar mineralization of collagen 
is the one of poly(allylamine) hydrochloride (PAH).[61,91–93]
It is hypothesized that the high content of anionic side chains 
in, e.g., pAsp, as well as its nonglobular, flexible nature, mimics 
the composition and structure of certain acidic NCPs found in 
vivo such as OPN, DMP1 and DPP, known to be involved in 
biomineralization processes.[94,95] These are classified as intrin-
sically disordered proteins that have a high content of charged 
side chains and lack a well-defined tertiary structure. However, 
not all aspects of the NCPs are present in polymeric analogs: 
often they lack the integrin- or collagen-binding sequences, 
phosphorylated serine/threonine content, or post-translation 
modifications such as glycosylation, and the role of these NCP 
motifs in biomineralization remains elusive.[96] The exception 
is perhaps the role of phosphorylated side chains, which were 
mimicked by the use of PVPA as process-directing agent, or by 
pretreating collagen with STMP. PVPA, either in solution or 
crosslinked to collagen, was able to induce intrafibrillar min-
eralization of reconstituted collagen fibrils and demineralized 
dentin, but only in the presence of PAA.[81,86] The phosphoryla-
tion of collagen fibrils by SMTP before immersion in a mineral-
ization solution (stabilized by PAA) was also shown to produce 
intrafibrillar mineral in reconstituted fibrils and demineralized 
dentin.[85,87]
These studies seem to suggest that the use of phosphoryl-
ated groups has a role in guiding the formation of intrafibrillar 
mineral, but not in stabilizing ACP itself, as this was accom-
plished by another biomimetic analog (PAA). The lack of 
quantification of mineral content in the collagenous matrix, for 
example by TGA, makes comparison with other mineralization 
strategies difficult. Moreover, the rather complicated minerali-
zation setup used in these studies, consisting of a combination 
of set Portland cement (as Ca2+ and OH− source) and a modi-
fied SBF (as PO43− source), as well as the necessary use of two 
biomimetic analogs makes this strategy rather complex for the 
results it yields.
Comparative studies on the effect of polymer concentra-
tion[79] and molecular weight[77] point toward pAsp of high 
molecular weight (highest reported is 32 kDa, but 27 kDa is 
more commonly used) as the best process-directing agent for 
achieving mineral content between 60 and 70 wt%, comparable 
to that of native bone. Similar ranges of mineral content were 
obtained by combinations of pGlu with pAsp, but there was no 
added benefit from the incorporation of pGlu.
The influence of polymer concentration is harder to gauge 
from the existing literature, because for many studies, the reac-
tion volume is not stated, and similar mineral content (wt%) 
is achieved with different concentrations, ranging from 10 to 
100 µg mL−1. One study analyzed the effect of concentration of 
pAsp (molecular weight 2–11 kDa) below 10 µg mL−1, finding 
that the rate of infiltration and mineralization slowed down 
with increasing concentration of the process-directing agent.[52] 
However, these results were obtained for collagen fibrils recon-
stituted on TEM grids, and the mineralization solution was less 
concentrated than typical PILP preparations (2.7 × 10−3 m CaCl2 
and 1.35 × 10−3 m K2PO4), making the comparison with other 
studies that often use bulk reactions for millimeter-sized sub-
strates difficult.
Another aspect that has been shown to affect the mineral 
content upon PILP-driven mineralization is the extent of col-
lagen crosslinking. For example, it has been demonstrated that 
a collagen sponge exhibited increased mineral content (48, 53, 
and 64 wt%) with an increase in crosslink density (26%, 59%, 
and 82% of free amine groups in collagen).[80] The mineraliza-
tion reaction of a 10 mg reconstituted collagen sponge using 
10.5 kDa pAsp (50 µg mL−1 in 100 mL) lasted for 14 days. When 
a (non-crosslinked) commercial sponge was used, the same 
level of mineralization was achieved after 16 days; however, in 
the latter case, the reaction volume used was 5 times higher 
(10.3 kDa pAsp (50 µg mL−1 in 500 mL)).[77] Taken together, 
these studies suggest that the crosslinking of collagen sub-
strates is an efficient way of improving mineralization kinetics. 
Moreover, crosslinking density was correlated with increasing 
stiffness and hardness of the composite, with the highest cross-
link density (82%) showing elastic modulus comparable to that 
of woven bone (around 0.2 GPa), even in the wet state.[80]
In a recent study by Shao et al., citrate was also shown to 
increase the mineral content of reconstituted collagen and 
demineralized dentin, when used in combination with pAsp-
assisted mineralization. Collagen gels were pretreated in a 
citrate-containing solution, before immersing in mineraliza-
tion medium, and showed increased residual mineral wt% with 
increasing concentration of citrate.[97]
Adv. Healthcare Mater. 2018, 7, 1800700
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One aspect that has not been extensively discussed or investi-
gated is the influence of the nature or properties of the collagen 
substrate itself on the mineralization by the PILP process. It 
is known that the nanometer-sized compartments, created 
during fibrillogenesis, and discernible through the emergent 
67 nm periodic D-spacing, are necessary for infiltration of the 
hydrated complexes, and also have a role in directing crystal-
lization and determining the final morphology of the apatite 
mineral.[56] Proper fibril formation appears to be the only nec-
essary condition for subsequent intrafibrillar mineralization. 
However, the collagen scaffolds used in the studies reported 
here have many different origins and have undergone different 
processing. For example, collagen substrates have been used 
as reconstituted fibrils or sponges (sometimes called mem-
branes) from acid- or enzyme-extracted collagen (that can be 
prepared in-house or purchased). They can originate from rat-
tail tendon,[61,75,91] bovine[77,79,90,92,93] or equine tendon,[52,56] or 
bovine skin.[30,68,80,81,83,85] Substrates have also been prepared 
directly from biological tissue, such as turkey tendon,[78] demin-
eralized sections from mouse periodontium,[57] and bone from 
manatee,[69,79] or fish[82] origin, as well as demineralized dentin 
from mouse,[72,73] or human origin.[70,71,74,86–89]
The versatility of the PILP process is attested by the mineral-
ization results with all these substrates. But considering the dif-
ferences between the reactions employed—conditions of fibril 
formation, molecular weight and concentration of the additive, 
reaction volume and time—one may question whether there 
is an underlying relation between the conditions required for 
successful mineralization and the properties of the substrate. 
In other words, are we simply selecting the conditions that 
work for a certain substrate, but missing some key aspect in 
the overall mechanism? This is supported by sporadic observa-
tions of heterogeneity of mineral deposition, more so in recon-
stituted than in tissue-derived collagen; and also by (possibly 
underreported) failed mineralization reactions upon aging of 
a collagen substrate known to have worked previously.[96] With 
the available information, this conclusion remains speculative, 
and therefore, more systematic studies are needed on the influ-
ence of collagen origin and processing on the efficiency and 
kinetics of mineralization.
In addition to pAsp and other polymers described above, 
whole (recombinant or purified) proteins have also been 
used for collagen mineralization studies, as mentioned in 
Section 1.[51,53–56] Inspired by the native proteins, some tailor-
made peptides and proteins have been developed and shown 
to play a role in CaP precipitation in vitro,[98] although a few 
attempts have been made to use them as NCP analogs in col-
lagen mineralization studies. Sfeir et al. used a peptide con-
taining a DPP-like motif, giving some insight into the possible 
phosphorylation mechanism of sequential serine residues, 
often found in NCPs.[99] Ping et al. used a multifunctional pro-
tein, containing a BSP-sequence and an HAP-binding motif 
that was shown to promote intrafibrillar mineralization of col-
lagen in the presence of poly(acrylic acid).[100] These studies 
have made an important contribution to the existing knowledge 
regarding the mechanisms of bone mineralization. Neverthe-
less, the number of studies in which tailor-made NCP analogs 
like these have been used to develop in vitro building blocks 
of bone is much lower than the studies where the far simpler 
synthetic polymers described above were used. Furthermore, 
the extent of mineralization obtained using these methods 
seemed to be inferior to, e.g., pAsp-driven mineralization.
Taken together, it can be concluded that our knowledge of the 
roles and importance of NCPs is still relatively limited. Never-
theless, continued research on biomineralization-related syn-
thetic peptides and proteins is warranted as such compounds 
may be useful in controlling, for example, the extrafibrillar min-
eral formation, in enhancing mechanical properties of synthetic 
bone substitutes, but also in less obvious ways, as replacements 
of collagen as the structural matrix, as described in Section 2.3.
2.2. Mimicking the Biological Apatite
Where the previous section focused on the methods to rep-
licate the intimate contact between apatite and collagen, 
here we zoom in into the properties of the mineral phase 
formed during intrafibrillar mineralization of collagen. It 
should be noted that while a large body of literature exists on 
methods to produce bone-like apatite (e.g., described in sev-
eral reviews[101,102]), here only the studies concerning mineral 
formed during intrafibrillar mineralization of collagen are 
discussed. In the previous section, it was shown that some 
excellent results were obtained on the nanoscale organization 
of organic and inorganic constituents of bone-like building 
blocks by using intrafibrillar mineralization of collagen. In 
contrast, less is known about the chemical composition of the 
deposited mineral phase, specifically regarding ionic substitu-
tions. Characterization of intrafibrillar mineral is mostly lim-
ited to TEM-SAED and X-ray diffraction (XRD) data, showing 
crystallite size and orientation, and crystallographic reflections 
matching those of bone apatite (TEM-SAED),[30] corroborated 
by similar XRD patterns between synthetic scaffolds and com-
pact bone.[80]
Small amounts of ions can sometimes have large effects 
of normal functioning of organs and tissues and on their 
repair and regeneration.[103,104] This is the concept behind the 
application of bioinorganics, which involves the use of (trace 
amounts of) ions to stimulate the regeneration of damaged 
tissue, much like a (organic) growth factor would do. This con-
cept as well as various methods of incorporation of bioinor-
ganics into, e.g., bone graft substitutes has been extensively 
discussed in several reviews.[102] It is therefore interesting to 
investigate whether bioinorganics can also be incorporated 
into the mineral deposited during intrafibrillar mineraliza-
tion of collagen. This would not only make “closer-to-nature” 
materials, in terms of their chemical composition, but would 
also plausibly enhance their bone regenerative potential. Only 
a few examples exist of such studies, although some substitu-
tions are to be expected due to the composition of the min-
eralization solution employed, containing carbonate, sodium, 
and potassium ions.
Characterization of the carbonate moiety by FTIR is typi-
cally done by deconvolution of the ν2 CO32− band between 
850 and 890 cm−1 into three different peaks: at 866 cm−1 for 
unstable location, 871 cm−1 for B-substitution (PO43− position), 
and 878 cm−1 for A-substitution (OH− position).[105] Inductively 
coupled plasma optical emission spectroscopy (ICP-OES) or 
Adv. Healthcare Mater. 2018, 7, 1800700
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mass spectrometry (ICP-MS) can provide good quantification 
of wt% of metallic ions, although by itself it is not sufficient to 
determine the exact position of the dopant, which can be incor-
porated into the crystalline lattice, adsorbed on the surface, or 
associated with the surrounding organic molecules. A comple-
mentary analysis by Rietveld refinement of diffraction data can 
substantiate evidence for the location of a substitute ion. This 
approach was used to characterize substitutions by Mn2+, Co2+, 
and Ni2+ in nanometer-sized citrate–carbonate–apatite (albeit 
in the absence of collagen, which could admittedly complicate 
the analysis), with good agreement between the theoretical pat-
tern (calculated for a certain % of substitution in Ca2+—data 
obtained by ICP-OES) and the experimental data.[106] Refine-
ment of the diffraction data was also used for characterizing 
Mg2+-substituted carbonated apatite and identifying preferential 
substitution in the Ca(II) position.[107] Other characterization 
methods to differentiate between adsorbed or lattice-incorpo-
rated dopants include 13P, 1H, or 43Ca solid-state nuclear 
magnetic resonance spectroscopy (NMR), which can give infor-
mation about the location of cation substitutions,[108–110] and 
small- and wide-angle X-ray scattering (SAXS and WAXS), 
which provides measurements of the lattice parameters, which 
are typically affected by substitutions from dopant ions with dif-
ferent radii. Additionally, SAXS/WAXS can also provide spatial 
resolution when used in the scanning mode.[111] Combination 
of electron microscopy with electron energy-loss spectroscopy 
(EELS) also offers chemical information with spatial resolution, 
as shown in a study where the formation of mineral deposits by 
mouse osteoblasts was observed to start from a CO32−-rich ACP 
nodule.[60] Other useful methods of chemical mapping include 
time-of-flight secondary-ion mass spectrometry[112,113] and atom 
probe tomography.[114]
Although in general, the techniques that have been used for 
chemical and structural characterization of bone can also be 
applied to the intrafibrillar mineral produced in vitro, to the best 
of our knowledge, they have been used to a very limited extent 
in biomineralization studies. One study mentioned that the 
addition of strontium to the mineralization solution “strongly 
disrupted the [PILP] process,” although no data were pro-
vided.[96] Strontium is known to decrease osteoclast-resorbing 
activity and differentiation, while promoting osteoblast differ-
entiation,[115,116] which makes it attractive for bone regeneration 
strategies. Another study focused on the interference of copper 
that was included in the mineralization solution by dissolution 
from TEM grids. The ion was shown to completely prevent 
mineralization by the PILP process, by overstabilizing the ACP 
precursor, which was shown to infiltrate the collagen fibrils 
but remain amorphous for at least 72 h.[52] Copper is a known 
stimulator of angiogenesis,[117] which is of great value for large-
defect regeneration.
Clearly, further research is necessary on the role of “for-
eign” ions in the polymer-induced mineralization process. It 
is important to understand whether they can be incorporated 
during the amorphous precursor formation phase or, as in the 
case of copper (and apparently strontium), they prevent the 
mineralization process altogether. This knowledge would not 
only increase our understanding of natural mineral formation, 
but could also aid the development of better performing bone 
graft substitutes.
2.3. Beyond Biomimetics: Replacing Collagen as the Structural 
Matrix for Biomineralization
Exploring synthetic biomaterials as a template for intrafibrillar-
like mineralization can contribute to the development of novel 
bone graft substitutes that do not rely on collagen sources. In 
general, collagen used in these types of studies and develop-
ments is animal-derived, and finding synthetic alternatives 
paves the way toward more ethically responsible and sustain-
able strategies for bone regeneration. Another advantage of 
replacing collagen as the organic structural matrix is that by 
using a designed and more controlled system, it is possible 
to better understand the role of individual properties of both 
the structural template and the process-directing agent in the 
biomineralization process. Replicating the nanoscale organiza-
tion of the organic–inorganic components of bone with syn-
thetic materials is, however, not trivial because it is in part due 
to the collagen structure and composition that the organiza-
tion of the apatite phase takes place, as pointed out by various 
studies.[55,56,66]
Nevertheless, a successful development was shown using 
the recombinant proteins elastin-like recombinamers (ELRs). 
These are recombinant proteins, inspired from a sequence 
derived from elastin, and capable of undergoing a soluble-
insoluble transition at a critical temperature (termed inversed 
transition temperature Tt), aggregating in a stable conforma-
tion. For temperatures above Tt, ELRs were shown to undergo 
intrafibrillar-like mineralization (Figure 3). Characterization by 
TEM-SAED showed that the self-assembled and crosslinked 
ELR matrix was mineralized with randomly oriented, needle-
like apatite crystals. X-ray diffraction confirmed the resem-
blance with bone apatite, and SEM-EDS showed maintenance 
of the hydrogel structural morphology and porosity despite 
extensive mineralization. Furthermore, mechanical characteri-
zation of the mineralized ELR was performed by nanoindenta-
tion both in dry and wet states, with bovine cortical bone used 
as control. The mineralized ELR had an elasticity modulus of 
20.3 GPa, comparable to that of cortical bone with a modulus 
of elasticity being 25 GPa. The hardness of mineralized ELR 
matrix and cortical bone in the dry state was 0.93 and 1.2 GPa, 
respectively. In the wet state, the mechanical properties of min-
eralized ELR were about one-third of those of cortical bone.[118]
A subsequent study by the same group gave evidence that 
the spaces created within ELR fibrils were responsible for its 
infiltration with the ACP precursor, and subsequent intrafi-
brillar mineralization. By using pAsp or PAH as process-
directing agents that create, respectively, negative and posi-
tive charged ACP–polymer complexes, mineralization of the 
positively charged ELR (due to lysine residues) occurred in 
both cases. This suggests that electrostatic interactions are 
not the driving force behind the infiltration of an amorphous 
phase, as mentioned in other studies.[56] It was also observed 
that the ELRs containing bioactive sequences formed gels that 
were less stable than the gels formed by ELRs containing the 
backbone sequence alone. It was hypothesized that the bio-
active sequences disrupted the otherwise stable secondary 
structures—β-spirals—that form at temperatures higher than 
Tt. However, mineral was reported to be found within the fibrils 
of all ELRs.
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The specific advantages of the ELR system stem from 
their recombinant nature. The ability to engineer specific 
peptide sequences allows controlled design of, for example, 
self-assembly properties, mechanical stability, or inclusion of 
bioactive sequences.[119] The drawback with recombinant pep-
tides is their cost, which currently poses a barrier to upscaling.
2.4. Scaling Up: From a Building Block to 2D and 3D Constructs
Organization of the building blocks into structures with dif-
ferent hierarchical levels is the next step in constructing a bone 
mimicking biomaterial/bone graft substitute. Referring to bone 
structure, fiber bundles and lamellae are the structures that are 
next on the length scale following single fibrils. At the 1–10 µm 
range, the emergent characteristic of fibril organization is the 
parallel array of fiber bundles.
Reconstituted fibrils from diluted acidic solutions generally 
have a random orientation. Many different attempts have been 
undertaken to align the fibrils along a given direction, and more 
in general, to structure collagen scaffolds.[120] The approaches 
we will discuss here are not exhaustive; they were selected 
only if the following three conditions were 
fulfilled: 1) the capacity to produce collagen 
fibrils that retain the periodic D-spacing; 2) 
the ability to form 2D or 3D structures that 
are relevant from a bone-mimicking per-
spective; and 3) the applicability to either in 
vitro cell models or potential for upscaling to 
larger, implantable constructs.
Electrochemically aligned collagen fibrils 
can be produced by generating an electric 
potential difference across a dialyzed col-
lagen solution. Using this method, fibril 
bundles were produced ranging from tens to 
hundreds of micrometers in thickness, and 
centimeters in length. Tropocollagen mol-
ecules align in a medium that is far from 
ideal for fibrillogenesis: they are at their 
isoelectric point (no charged residues) and 
there is close to zero ionic strength, due to 
the dialysis step. Subsequent incubation 
in phosphate-buffered saline is critical for 
allowing proper fibril formation. The pro-
cess can be complemented with crosslinking. 
Although the characteristic D-spacing pat-
tern could not be confirmed by SEM or TEM, 
the SAXS pattern showed similarity with 
that of a natural tendon. While this method 
is promising for the production of large 
and oriented collagen structures, more data 
is needed on the conservation of the native 
fibril conformation.[121,122]
A combination of wet spinning, fibrillo-
genesis step, and subsequent application 
of uniaxial strain (15% or 30%) produced 
highly aligned, elliptical-shaped fibrils, with 
the cross-sectional dimensions of about 
50 × 20 µm. D-spacing of the fibrils was con-
firmed by TEM, although some unbanded parts were still pre-
sent (Figure 4). This method was used to produce fibers that 
were hundreds of meters long.[123] Wet spinning uses a com-
bination of solvents that is typically not compatible with the 
self-assembly of tropocollagen into native quarter-staggered 
conformation, so a second incubation step is necessary, where 
the drawn “amorphous” collagen fiber is immersed in a fibril 
formation buffer, e.g., PBS. The impact of the spinning pro-
cess on the capacity of the tropocollagen molecules to assemble 
within the already drawn fiber is not clear, and more studies 
are needed to characterize the fibrillogenesis process after wet 
spinning. Nonetheless, this method shows great promise for 
scaling up: from drawn fibers of collagen into 2D sheets with 
control over fiber orientation, for example, by using weaving 
techniques and potentially into 3D scaffolds.[124,125]
Magnetic fields have also been used for aligning collagen 
gels, as the tropocollagen molecule has a permanent dipole, 
as does the aggregated fibril. A strong magnetic field (12 T) 
was applied to a 5 mm thick collagen gel (9 mg mL−1) for 3 h, 
resulting in alignment of about 85% of the fibers within 10° 
of the expected direction, as was shown by the SEM micro-
scopic images.[126] While these microscopic images only 
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Figure 3. Intrafibrillar mineralization of an ELR sponge. a) SEM image of an ELR sponge min-
eralized for 7 days, b) bright field TEM image of an ELR fiber mineralized for 14 days, and 
c) corresponding SAED pattern showing relatively random distribution of the c-axis compo-
nents 002 and 004, as well as reflections from the 211, 112, 300, and 210 planes. Reproduced 
with permission.[118] Copyright 2015, American Chemical Society.
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showed the gel surface, it would be interesting to investigate 
the alignment of the fibers in the bulk of the thick gels. For-
mation of fibrils with periodic D-spacing was not disturbed 
by the magnetic field, as shown by SEM[127] and AFM.[126] 
Weaker magnetic fields were also able to induce alignment 
of fibrils, provided that magnetic particles (e.g., iron oxide 
nanoparticles) were embedded in the collagen matrix.[128,129] 
However, the presence of these extra particles could hamper 
the mineralization process.
Using a soft lithography method microtransfer molding 
(µTM), Naik et al. were able to produce collagen patterns on flat 
surfaces, although with little evidence about their native con-
formation.[130] Also several microfluidic-based methods were 
used for producing aligned collagen fibrils. A flow-assisted 
patterning method using parallel microchannels was used to 
deposit aligned fibrils. It was shown that smaller channel width 
led to increasing frequency of alignment, with 10 µm wide 
channels having about 40% fibers within 5° of the channel 
direction.[131] These strategies, although useful for producing 
2D substrates for studies on cell–material interaction, have lim-
ited potential for upscaling into 3D structures. A study using 
hydrodynamic focusing showed a great potential for contin-
uous production of a collagen fiber of controllable width, in a 
manner similar to wet spinning, but with overall smaller fiber 
diameters and more control over the diameter (Figure 5).[132] 
Although the conditions of fibrillogenesis in these studies are 
amenable to formation of the native D-spacing, the data proving 
this were largely absent in these studies.
Adv. Healthcare Mater. 2018, 7, 1800700
Figure 4. Wet spinning for collagen fibril alignment. a) Schematic of the wet spinning setup, showing syringes i,ii) with collagen and buffer solutions 
that are injected into a needle iii), housed in a bubble trap iv), with a glass capillary v) leading to a bath containing the fiber formation buffer vi); fibers 
are collected manually vii) or automatically in a spool viii), and finally go through a 70% ethanol bath before being air dried ix); b) bright field TEM of 
sections of collagen fibers stained with 2% uranyl acetate after being subjected to 15% or 30% strain. While low-magnification images (left column) 
show highly aligned fibers, close inspection reveals in both cases areas of disorder (middle column) and order (right column) within the same fiber. 
Reproduced with permission.[123] Copyright 2009, Wiley Periodicals.
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Apart from fibril orientation, another important charac-
teristic for production of 2D or 3D collagen constructs is the 
packing of collagen molecules, and the den-
sity of the final material. Again, referring to 
the composition of natural bone, a biomim-
icking material should contain ≈65 wt% apa-
tite, 25 wt% organic matter and a maxi mum 
of about 10 wt% water. Some examples of 
intrafibrillar mineralization studies pre-
sented in the previous section reported 
mineral content, as determined by TGA, of 
around 65 wt%.[77,80] However, as most sam-
ples are lyophilized before the analysis, the 
reported weight percentages are those of the 
dry substrate.
This value is often compared directly with 
the inorganic content of bone cited in the lit-
erature, of 65 wt%, without mention of the 
water content in the scaffold. It should be 
noted that the 65 wt% pertains to wet bone, 
and that the corresponding weight percentage 
of inorganic content in a dry sample would 
is about 72 wt%. So if a mineralized and lyo-
philized collagen scaffold shows 65 wt% inor-
ganic content, this is still very comparable 
to the 72 wt% found in bone. This means 
that the collagen fibrils (and not the scaffold 
as a whole) have a mineral content that is 
indeed close to that of bone fibrils. Indeed, 
the in vitro-prepared substrates have higher 
porosity and take up much more than the 
10 wt% water that bone usually contains. 
This becomes apparent when the mechanical 
properties of the biomineralized materials are 
measured in the wet state. Under wet condi-
tions, the elastic modulus and hardness are 
generally much lower than what would be 
expected if the water content of such a mate-
rial would be similar to that of bone.[80] The 
concentrations of commercially available 
acidic solutions of collagen range from 2 to 
10 mg mL−1, which is 25–125 times lower 
than in natural bone. This means that in 
order to have a substrate with around 10 wt% 
of water, common collagen solutions or gels 
have to be concentrated. A few approaches 
to produce dense matrices from diluted 
solutions of collagen have been described.
For example, based on reports that collagen 
exhibits a behavior similar to liquid crys-
tals at high concentrations (>80 mg mL−1), 
assembling into a cholesteric structure in 
vitro that is reminiscent of the angular step 
between adjacent lamella,[133,134] Wang et al. 
produced organized and dense matrices from 
a diluted collagen solution, via a combination 
of injection and reverse dialysis.[135] TEM and 
SEM microscopic images of these dense scaf-
folds showed features with some similarity to 
osteonal bone, while collagen fibrils showed the characteristic 
D-spacing, confirming that they were well formed.
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Figure 5. Microfluidic extrusion of collagen fibrils by hydrodynamic focusing. a) Schematic of 
the setup, with two inlets for buffer solution (blue) and one for the collagen solution (red); 
the microfluidic chip is housed inside a beaker with fiber formation buffer, where the fiber 
passes through while being collected by a spool. This technique allows great control over fiber 
diameter, as seen in the images of different fiber diameter produced at different flow rates. 
b) SEM image of a collagen fibril produced using this system. Reproduced with permission.[132] 
Copyright 2016, American Chemical Society.
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Due to the method used, with injection (8 days), dialysis 
(4 days), and fibrillogenesis (4 days), the entire process was 
lengthy, compounded with 16 additional days to achieve 50 wt% 
mineral content. Nevertheless, a dense scaffold was formed, 
showing a degree of organization that bears some resemblance 
to osteonal bone, which is a notable achievement.
Extensive and homogeneous mineralization of large, dense 
scaffolds remains a challenge, as was also illustrated by the rela-
tively limited infiltration depth of PILP precursors in demineral-
ized bone (up to 100 µm)[69] and tendon tissue (up to 500 µm).[76]
An alternative method to obtain dense collagen scaffolds in vitro 
is by applying compression to typical collagen gel formulations, 
increasing their concentration by forcing out the water.[136,137] This 
approach was used by Li et al. to obtain dense collagen matrices, 
in the form of a 100 µm thick membrane with collagen concen-
tration of around 80 mg mL−1.[80] Homogenous mineralization 
by the PILP method was confirmed by SEM-EDS analysis of a 
cross-section of the membrane. This method yielded randomly 
oriented fibrils and a substrate that was less dense than the ones 
produced by the injection-dialysis method described above. After 
crosslinking and mineralization (64 wt% dry weight), the mem-
brane had an elastic modulus of 9 GPa and hardness of 0.7 GPa, 
which were about one third of the values for lamellar bone in 
the dry state. When measured in the wet state, the mechanical 
properties decreased even further, reaching the elastic modulus 
of around 0.2 GPa, close to that of woven bone in the wet state. 
This comparison shows that, in order to mimic the mechanical 
properties of bone, further compaction of the collagen matrix, in 
combination with successful mineralization, is necessary.
Design of osteon-like structures that replicate its level of hier-
archical organization is a difficult task to undertake. Current 3D 
printing techniques focus on the reconstruction of the central 
Haversian canal and network of micro channels surrounding it, 
typically using a biocompatible polymer like poly(lactic acid).[138] 
Printing techniques, however, are not capable of achieving 
high collagen density. An alternative approach could include a 
reverse-dialysis or compression method on a collagen gel con-
taining a sacrificial framework that would be washed away in a 
subsequent step, creating a network of interconnected channels 
within a dense scaffold.
2.5. Evaluation of Bioactivity
An important step in research and development of biomaterials 
for bone regeneration is the investigation of their interactions 
with relevant cells in vitro, such as osteoblasts, mesenchymal 
stem cells, etc., as a means to evaluate their bioactivity. Interest-
ingly, only a limited number of studies exist in which collagen 
substrates with intrafibrillar mineralization were evaluated in 
vitro using cell culture systems.
In one of these studies, a crosslinked and phosphorylated 
collagen gel was formed on coverslips and mineralized using 
an SBF-like solution containing PAA. This substrate was used 
for culturing human periodontal ligament stem cells up to 
21 days, in culture medium without stimulators of osteogenic 
differentiation. Controls included a collagen scaffold mineral-
ized in the same SBF-like solution, but without PAA, as well 
as unmineralized collagen. Quantification of osteogenic gene 
expression showed upregulation of OPN, COL1A1, and BMP2 
mRNA on the intrafibrillar mineralized collagen as compared 
to the controls. Moreover, alizarin red staining showed more 
pronounced mineralization on the scaffolds with intrafibrillar 
mineralization.[139]
In another study, an intrafibrillar-mineralized collagen 
scaffold was prepared using phosphorylated collagen and PAA, 
followed by the 21 day culture of human umbilical cord mesen-
chymal stem cells. Controls included collagen mineralized in 
the absence of PAA, nonphosphorylated mineralized collagen 
and unmineralized collagen. ALP activity of the cells cultured 
on intrafibrillar-mineralized collagen scaffold was higher than 
on the controls only after 21 days, while no differences were 
observed at earlier time points. These constructs were also 
implanted in a femoral bone defect model in rabbits. Com-
plete defect healing after 12 weeks was only shown for the 
intrafibrillar-mineralized collagen, by the MRI and micro-CT 
analyses.[140]
A collagen scaffold with intrafibrillar mineralization, pre-
pared with carboxymethyl chitosan as process-directing agent, 
was used for culturing mouse MC3T3-E1 osteoblast-like cells, 
for 7 days. An SBF-mineralized collagen scaffold and a col-
lagen-only scaffold served as controls. ALP activity was higher 
for the scaffold with intrafibrillar mineralization after 5 and 
7 days, although not at the earliest time point. These constructs 
were also implanted in a cranial defect model in rats, where 
only the intrafibrillar-mineralized scaffold showed almost com-
plete defect closure within 8 weeks, as demonstrated by µCT 
and histological data.[141]
In an elegant study by Jiao et al., a biphasic silica/apatite 
mineralized collagen scaffold was prepared by a two-step PILP-
like procedure, where PAH was used for stabilization of the 
silica-containing medium, and pAsp for the CaP-containing 
medium. Controls included a silicified-collagen substrate, a 
calcified-collagen substrate, and a collagen-only substrate. The 
in vitro cell culture was performed using mouse mesenchymal 
stem cells, as well as mouse macrophage cell line RAW264.7, 
capable of undergoing differentiation toward osteoclasts. The 
differentiation of mMSC in osteogenic medium, assessed by 
the ALP activity, was highest on the biphasic scaffold. Quan-
titative real-time polymerase chain reaction showed a strong 
effect of silica incorporation: upregulation of ALP, OPN, and 
OPG on the one hand, and downregulation of osteoclast-
activating RANKL on the other, for the biphasic and silica– 
collagen scaffolds. When biphasic and silica–collagen scaffolds 
were compared, a higher expression of the osteogenic markers 
was observed on the former type. The OPG upregulation and 
RANKL downregulation were confirmed by the Western blot 
analysis. Furthermore, in a coculture of RAW264.7 cells with 
scaffold-conditioned mMSC, it was shown that the number of 
TRAP-positive cells and area of resorption pits were decreased 
for conditions where the mMSC were cultured on silicified and 
biphasic scaffolds. The authors further completed the study by 
uncovering the signaling pathways behind the observed mecha-
nism of inhibition of osteoclastogenesis through a series of 
pathway-inhibition experiments.[93]
Another study used OPN- or pAsp-assisted mineralization 
of demineralized slices of bovine femur, and compared the 
influence of the process-directing agent on mouse osteoclasts 
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derived from bone marrow. Controls were unaltered bone 
slices, as well as demineralized slices that were remineralized 
in the absence of OPN or pAsp. Immunofluorescence and SEM 
results showed, respectively, that the number of actin rings 
and resorption pits formed were lower on the pAsp-reminer-
alized slices than on the unaltered bone slices. In contrast, the 
number of actin rings and resorption pits was higher when the 
slices were remineralized by OPN.[53] These results suggest that 
OPN has a role in cell-mediated bone resorption, corroborated 
with evidence for less resorption by OPN-deficient mice.[142,143]
Although limited in number, the available studies on the in 
vitro bioactivity of intrafibrillar-mineralized collagen scaffolds 
show promising results, both in terms of support of differ-
entiation of multipotent stem cells toward the osteogenic lin-
eage, as well as for being able to be resorbed by cell-mediated 
phenomena. The two in vivo experiments[140,141] reviewed also 
show promising results, with better healing of bone defects 
when compared to the respective controls.
Continued biological experiments to evaluate the bioactivity 
of bone-mimicking substitutes are a necessity, to validate mate-
rial design and investigate whether pursuit of the biomimetic 
route indeed delivers on its promises.
2.6. Translation to the Clinic
Some efforts have been made to translate the amorphous 
precursor systems into clinical strategies for remineralization 
of hypo-mineralized tissues, as solution-based systems have 
limitations for application in a clinical situation. Typically these 
efforts involve the use of a carrier system to deliver the mineral-
izing components to the target tissue. For example, mesoporous 
silica nanoparticles were loaded with PAA-stabilized ACP, and 
used for mineralizing reconstituted collagen fibrils in vitro. 
TEM analysis showed the presence of intrafibrillar mineral, 
throughout the collagen network, after 4 days.[144,145]
Another example is the use of self-etch adhesives, currently 
used in the treatment of dental cavities, as a carrier system for 
pAsp-stabilized silica-doped ACP. When tested on demineral-
ized dentin, the adhesives produced a 1–2 µm layer of lightly 
remineralized tissue after 14 days, close to the native dentin.[146]
These examples show a simple and effective way of trans-
lating an in vitro concept of biomineralization directly to a 
clinical setting, and are a promising first step toward developing 
biomimetic remineralization systems. The current challenges 
are related to volume of mineralizing components that can be 
delivered; the adhesive mentioned above was loaded with 25 wt% 
of amorphous precursor particles, which could potentially be 
increased, but not by a large amount. Alternative strategies 
could focus on using the mineral ions present in surrounding 
physiological fluids as the source for continued mineralization.
3. Conclusion and Outlook
Successful intrafibrillar mineralization of collagen substrates 
in vitro, achieved in the past decade, has been an important 
step forward toward truly biomimetic bone-like structures. 
As is evident from the different studies reviewed here, the 
lab-made building blocks closely replicate some of the most 
important features found natural tissue, such as mineral den-
sity, particle size, and crystallite orientation. Nevertheless, for 
some other characteristics, it is still unclear to which extent the 
in vitro built structures resemble their natural counterparts. 
For example, more characterization of the chemical identity 
of the in vitro formed intrafibrillar mineral is required, in par-
ticular regarding the substitutions by ions present in the min-
eralizing solution. This could deliver further insights into the 
mechanism of polymer-assisted mineralization as some ions 
were shown to disrupt the process. Furthermore, while pre-
sent in low (often trace) amounts in natural bone mineral, the 
relevance of these ions should not be ignored; on the contrary, 
bioinorganic additives to the mineral may enhance the bone 
regenerative potential to the biomimetic bone graft substitutes.
This review has also shown the importance of advanced 
analytical techniques in understanding the natural process 
of biomineralization, which in turn should be applied to the 
design and development of new biomimetic biomaterials. 
For example, the curved needle–like crystallites, shown by 3D 
reconstruction of HR-TEM of bone slices to interpenetrate 
more than one collagen fibril,[31] put in question the division 
between intrafibrillar and extrafibrillar mineral and beg for new 
hypothesizes regarding the formation of these structures. Fur-
thermore, continued research toward full understanding of the 
roles of NCPs in bone mineralization might shed light upon 
the crystallization process of these particles.
Research into and development of (synthetic) alternatives 
to collagen as structural component of the ECM is also highly 
important for two reasons. First, the use of synthetic, often 
well-characterized materials may contribute to the knowl-
edge of the fundamentals of biomineralization, for example, 
regarding the role of NCPs, by allowing a direct comparison 
with collagen. Second, the development of collagen alternatives 
is highly important from a translational perspective, where 
the use of a synthetic material has several advantages over the 
(xenogeneic) collagen. The only system that has shown con-
vincing intrafibrillar-like mineralization is based on recombi-
nant proteins, which add versatility and customization features, 
but are expensive for upscaling. Therefore, efforts to develop 
other alternative matrices that can overcome this issue are 
justified. As exemplified by the ELRs, and also by a study on 
mineralization upon physical confinement,[147] a critical feature 
for intrafibrillar-like mineralization seems to be the existence 
of stable, structural confined spaces. This is achieved in both 
collagen and ELR by the assembly of small building blocks, of 
tropocollagen and β-spirals, respectively, into larger hierarchical 
structures—collagen fibrils (staggered tropocollagen molecules) 
and ELR filaments (association of folded β-spirals). It is envi-
sioned that by this same principle of producing stable molec-
ular structures with nanoporosity, other polymeric systems can 
be used for intrafibrillar-like mineralization.
Upscaling from a building block into organized 2D and 3D 
assemblies comes with two main challenges: directionality 
of the collagen fibers and compact arrangement into dense 
substrates.
State-of-the-art methodologies capable of aligning collagen 
fibrils while retaining their capacity for bone-like miner-
alization come from many different fields. Of note are wet 
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spinning[123] and microfluidic[132] approaches that have the 
potential to produce aligned bundles of fibers with the native 
D-spacing, as well as the advantage of having some control over 
fiber diameter.
These can be combined with other techniques, for example 
weaving of biopolymers,[125] to fabricate 2D bidirectional 
meshes of parallel collagen fibers. Control over the fibril 
thickness and pore dimension, and further stacking of 2D 
meshes would result in a 3D structure structurally resembling 
cancellous bone.
It should be emphasized that one of the main reasons for 
pursuing the biomimetic approaches to develop synthetic bone 
graft substitutes is the potential to match the mechanical char-
acteristics of natural bone, which cannot be achieved with cur-
rently widely used (CaP) ceramic bone graft substitutes, which 
are intrinsically brittle. Interestingly, in many studies reviewed 
here, the mechanical properties have not been extensively 
evaluated, while specific mechanical tests would be useful, for 
example, in determining the importance of fibril alignment.
It has been shown that the elastic modulus of synthetic scaf-
folds is about 33% (for ELR) and 13% (for collagen) of that of 
lamellar bone. This difference can be attributed to an insuffi-
cient fibril density of the synthetic scaffolds, which generally 
perform poorly when in the wet state. Replication of the cortical 
bone density requires the mineralization of large collagen sub-
strates with limited porosity (≈6%), which is a challenging task. 
The study by Wang et al. is a good example of exploiting the 
liquid-crystal behavior of collagen solutions, at high concentra-
tions, to form dense collagen substrates that also show some 
degree of fiber orientation.[66] Another promising method is 
the use of plastic compression applied to gels with prealigned 
fibrils, obtained, for example, using magnetic fields.
While 3D constructs are essential from a translational/
clinical perspective, planar structures are a necessary step in 
getting there, meanwhile being useful for cell–material inter-
action studies that provide data to sustain further develop-
ments of biomimetic materials. As discussed in the last section 
of the review, the number of studies dealing with the interac-
tions between relevant cells and the latest wave of biomimetic 
materials for bone regeneration is limited. Nevertheless, the 
results of these studies are compelling. In particular, further 
studies concentrating on the interplay between osteoblasts 
and osteoclasts would be useful in establishing a model for 
resorption and replacement of these synthetic substrates by 
natural bone ECM.
It must be noted that the reason for choosing a biomimetic 
route to biomaterial design and development does not come 
solely from its potential to deliver better materials for the clinic. 
Indeed, no consensus in the field of materials for biomedical 
applications exists that biomimetic or bioinspired methods are 
more promising than other methods for developing successful 
treatments of damaged and diseased organs and tissues. Nev-
ertheless, by using more natural-like strategies in vitro, it is 
sometimes possible to link laboratory evidence to actual in vivo 
mechanisms, as was the case for the discovery of amorphous 
precursors in vertebrate bone. The combination of fundamental 
and applied studies that take place at the biomimetic border 
fuels each other into new discoveries, and this is one of the 
main strengths of biomimetism.
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